Marked erythropoietin-induced dysplastic erythropoiesis in a patient with myelodysplastic syndrome Kensuke NarukawaAkiko MasudaTsuyoshi Takahashi Images in Hematology 17 April 2021 Pages: 775 - 776
Pembrolizumab plus pomalidomide and dexamethasone for relapsed or refractory multiple myeloma (KEYNOTE-183): subgroup analysis in Japanese patients Morio MatsumotoKenshi SuzukiShinsuke Iida Rapid Communication 15 April 2021 Pages: 777 - 784
Unrecognized blood clotting factors Hidehiko SaitoTetsuhito Kojima Review Article 20 March 2021 Pages: 785 - 788
Predicted coagulation potential using an in vitro simulated model of emicizumab prophylaxis and immune tolerance induction therapy in hemophilia A patients with inhibitor Yuto NakajimaHitoshi TonegawaKeiji Nogami Original Article 26 February 2021 Pages: 789 - 796
A phase I, dose-escalation study of oral PIM447 in Japanese patients with relapsed and/or refractory multiple myeloma Shinsuke IidaKazutaka SunamiMasafumi Taniwaki Original Article 27 February 2021 Pages: 797 - 806
Stanozolol improves the progression-free survival of patients with high-risk myelodysplastic syndrome after decitabine treatment Yumei LiuChen YangZonghong Shao Original Article 01 March 2021 Pages: 807 - 814
Clinical features and chromosomal/genetic aberration in adult acute lymphoblastic leukemia in Japan: results of Fukuoka Blood & Marrow Transplant Group Studies ALL MRD 2002 and 2008 Satoshi MorishigeToshihiro MiyamotoKoji Nagafuji Original Article 16 March 2021 Pages: 815 - 822
Primary prophylaxis with pegfilgrastim during the first cycle of R-CHOP to avoid reduction of dose intensity in elderly patients Masataka IseKensuke MatsudaMineo Kurokawa Original Article 18 March 2021 Pages: 823 - 831
Minimal residual disease (MRD) positivity at allogeneic hematopoietic cell transplantation, not the quantity of MRD, is a risk factor for relapse of Philadelphia chromosome-positive acute lymphoblastic leukemia Yu AkahoshiYasuyuki AraiShinichi Kako Original Article 11 February 2021 Pages: 832 - 839
Effect of methotrexate dose in graft-versus-host disease prophylaxis after single-unit cord blood transplantation in adult acute myeloid leukemia Seitaro TerakuraYachiyo KuwatsukaTakanori Teshima Original Article 21 February 2021 Pages: 840 - 850
Autologous hematopoietic cell transplantation following high-dose cytarabine consolidation for core-binding factor-acute myeloid leukemia in first complete remission: a phase 2 prospective trial Eun-Ji ChoiJe-Hwan LeeCoOperative Study Group A for Hematology (COSAH) Original Article 02 March 2021 Pages: 851 - 860
Cord blood transplantation with a reduced-intensity conditioning regimen using fludarabine and melphalan for adult T-cell leukemia/lymphoma Nobuaki NakanoYoshifusa TakatsukaAtae Utsunomiya Original Article 16 February 2021 Pages: 861 - 871
Drug interaction between letermovir and voriconazole after allogeneic hematopoietic cell transplantation Toshihisa NakashimaYoshihiro InamotoMasakazu Yamaguchi Original Article 07 March 2021 Pages: 872 - 876
Phase 1 study of plerixafor in combination with total body irradiation-based myeloablative conditioning for allogeneic hematopoietic stem cell transplantation Takehiko MoriTaku KikuchiJun Kato Original Article 01 March 2021 Pages: 877 - 883
Cardiovascular risk factors among adult patients with haemophilia Ricardo Mesquita CameloCamila Caram-DeelderJohanna van der Bom Original Article 07 March 2021 Pages: 884 - 892
Prednisolone poor response is not an indication for HSCT in pediatric B-cell precursor acute lymphoblastic leukemia in first remission: results from JACLS ALL-02 study Hisashi IshidaMio YanoToshihiko Imamura Original Article 28 February 2021 Pages: 893 - 902
Real-world outcomes of AIDS-related Burkitt lymphoma: a retrospective study of 78 cases over a 10-year period Zhenyan WangRenfang ZhangHongzhou Lu Original Article 17 February 2021 Pages: 903 - 909
Utility of novel T-cell-specific extracellular vesicles in monitoring and evaluation of acute GVHD Masayuki NagasawaNoriko MitsuikiTomohiro Morio Original Article 08 March 2021 Pages: 910 - 920
Safety and tolerability of IgPro10 in Japanese primary immunodeficiency patients: a registrational study Tomohiro MorioKenji GotohMikhail A. Rojavin Original Article 18 March 2021 Pages: 921 - 929
Clot waveform analysis for perioperative hemostatic monitoring of arthroscopic synovectomy in a pediatric patient with hemophilia A and inhibitor receiving emicizumab prophylaxis Kuniyoshi MizumachiYusuke TsumuraKeiji Nogami Case Report 10 February 2021 Pages: 930 - 935
Development of Philadelphia chromosome-negative acute myeloid leukemia with IDH2 and NPM1 mutations in a patient with chronic myeloid leukemia who showed a major molecular response to tyrosine kinase inhibitor therapy Fumi NakamuraHonoka AraiKinuko Mitani Case Report 05 January 2021 Pages: 936 - 940
Successful upfront cord blood transplantation for plasma cell leukemia in the first complete response after daratumumab therapy Toshiyuki UenoYasuhiro SugioYuju Ohno Case Report 22 January 2021 Pages: 941 - 944
Down syndrome with neonatal alloimmune thrombocytopenia due to anti-HLA A31 and B61 antibodies Eriko ShimaHayato GoMitsuaki Hosoya Case Report 11 February 2021 Pages: 945 - 949
Correction to: Cord blood transplantation with a reduced-intensity conditioning regimen using fludarabine and melphalan for adult T-cell leukemia/lymphoma Nobuaki NakanoYoshifusa TakatsukaAtae Utsunomiya Correction 17 March 2021 Pages: 950 - 950
